Fig. 2From: Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitisColumn graphs depicting domains and selected dimensions used in pre-specified primary outcome measures of efficacy in uveitis clinical trials. a, b Dimensions according to whether primary outcome measure was single, multiple, or composite. c Activity domains, according to whether primary outcome measure was single, multiple, or compositeBack to article page